Filter Results:
(125)
Show Results For
- All HBS Web
(125)
- People (1)
- News (52)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (30)
Show Results For
- All HBS Web
(125)
- People (1)
- News (52)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (30)
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
significantly enhanced safety and efficacy. We're initially targeting neuropsychiatric diseases characterized by aberrant PPIs of epigenetic protein complexes. Oliver's background includes six years at Ginkgo Bioworks, where he led pharma... View Details
- 15 Nov 2022
- Book
Stop Ignoring Bad Behavior: 6 Tips for Better Ethics at Work
In 1995, Purdue Pharma began selling a powerful and addictive opioid drug called OxyContin. The company was aware that the drug, which was marketed to doctors as a safe way to manage chronic pain, was a potent narcotic that could quickly... View Details
Keywords: by Pamela Reynolds
- 19 Sep 2023
- Research & Ideas
What Chandrayaan-3 Says About India's Entrepreneurial Approach to Space
appeared in the Harvard Gazette. Interview has been edited for clarity and length. You Might Also Like: 5 Qualities That Help Companies Thrive for Decades—Even Centuries When Experts Play It Too Safe: Innovation Lessons from a NASA Experiment Could a Business Model... View Details
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
differences in response to different types of customers,” Stern says. “To the extent those exist, that means you’re not serving a certain group of customers, and you’re potentially leaving money on the table.” You Might Also Like: The FDA’s Speedy Drug Approvals Are... View Details
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- Web
Fast Facts - Health Care
Health Care Initiative Fast Facts Events 1,325 Alumni attended Health Care Initiative events in 2019 MBA Health Care Career Placement 2018 Biotech / Pharma Consulting Devices & Diagnostics Digital Health & Other Services Financial... View Details
- 01 Jun 2023
- News
Bridging the ESG Data Gap
opportunity and responsibility to tackle the most pressing issues of our time,” she states. “Our company empowers venture investors and founders to do just that.” NURTURING BREAKTHROUGH IDEAS An Engine of Innovation From Big Pharma to... View Details
Keywords: Deborah Blagg
- 29 May 2023
- News
Nurturing Breakthrough Ideas
alumni and friends affirms its mission—to serve as an educational springboard that fosters peer collaboration beyond the boundaries of a particular Harvard school, enabling innovators to create meaningful impact across industries, sectors, and continents. An Engine of... View Details
- Web
Recruiting Partners - Health Care
Carmot Therapeutics CCD International Cedars-Sinai Health System Celgene Corporation Cerner Corporation Cerulean Pharma Inc. Children's Healthcare of Atlanta Children's Hospital Boston Church & Dwight Co., Inc. Cigna City Health Works... View Details
- 01 Jun 2023
- News
Cultivating Prosperity in Afghanistan
being a force for good and in the ability of a for-profit social enterprise to lay a sustainable foundation for our partners in Afghanistan to connect with people around the world.” “What better way to use our HBS education than for sustainable agriculture and business... View Details
Keywords: Jennifer Gillespie
- Research Summary
Career Histories and the Biotechnology Industry
Professor Higgins' other major project focuses on the consequences of individuals' career experiences for firms and industries. This second research stream centers on the careers of executives in the biotechnology industry.
Professor Higgins has written... View Details
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
continuing to address health insurance problems piecemeal will only create further fractures. The US needs to work on fostering “universal access to innovative care in an affordable system,” they say. You Might Also Like: The FDA’s Speedy Drug Approvals Are Safe: A... View Details
- 22 Nov 2004
- Research & Ideas
Side Effects: The Case of Propecia
wives, believing such campaigns would not be cost effective. As Wosinska put the problem: "How does a pharma talk to barbers?" In the end, first-year sales beat internal estimates, thanks to pent-up demand. Propecia is now a... View Details
- 01 Jun 2023
- News
An Engine of Innovation
Bridgitt Evans Executive Director, Harvard Innovation Labs NURTURING BREAKTHROUGH IDEAS From Big Pharma to Startup Cultivating Prosperity in Afghanistan Bridging the ESG Data Gap View Details
Keywords: Jennifer Gillespie
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
pharma – but the tides are changing. The underserved nature of the rare disease population combined with increases in federal funding, biotech and medical advancements are spurring optimism for the future. Growth in the markets for... View Details
- 12 Jun 2018
- Research & Ideas
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
not difficult for pharma firms. Companies tended to “either have projects on the shelf or projects that they are excited to go do when they get a little more buffer or get a little more cash,” Krieger says. Ask yourself a question What’s... View Details
- Fast Answer
Pharmaceuticals: Company Data and Analysis
not only information on pharma companies, but also covers drug pipelines and global trials, pharma deals, drug sales, and patents. Access is available to HBS AND HU students, staff and faculty onsite at... View Details
- 01 Dec 2004
- News
Finding a Balance
pirate by global pharmas that consider Cipla’s products a direct rip-off of patented drugs. From 1999 through 2002, Cipla enjoyed an average annual growth rate of 30.3 percent from the sale of more than 400 drugs, including generic... View Details
- 01 Dec 2019
- News
The Race Against Resistance
with the rise of antibiotic-resistant superbugs. “We are approaching a cliff,” says Anna Diaz Triola (MBA 2000), vice president of marketing at Summit Therapeutics in Cambridge, Massachusetts, which is part of a cohort of small pharma... View Details
Keywords: Lisa Scanlon Mogolov
Eric Boutin
Eric Boutin is a digital health investor, board member, and serial entrepreneur, helping early-stage startups to global pharma companies reimagine healthcare through science and technology. Eric helps founders launch, fund, and scale... View Details
Keywords: Healthcare